3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Prostatic Neoplasms
1
Patient Satisfaction
1
Neuromuscular Junction Diseases
1
Nervous System Diseases
1
Neoplasms
1
Myasthenia Gravis
1
Muscle Weakness
1
Immune System Diseases
1
COVID-19
1
Autoimmune Diseases of the Nervous System
1
Autoimmune Diseases
1
Interventions
ravulizumab
3
Tacrolimus
3
Pyridostigmine Bromide
3
Prednisone
3
Mycophenolic Acid
3
Data Collection
3
Azathioprine
3
efgartigimod alfa
2
Steroids
2
Diagnostic Self Evaluation
2
Blood Specimen Collection
2
rozanolixizumab
1
Thymectomy
1
Therapeutics
1
Telemedicine
1
Neurofeedback
1
Methylprednisolone
1
Methotrexate
1
Immunosuppressive Agents
1
Immunoglobulins, Intravenous
1
Genotype
1
Cyclosporine
1
Cyclophosphamide
1
Biomarkers
1
Alleles
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Myasthenia Gravis
×
Telemedicine
×
Clear all
NCT05917184
2023-06-23
ADAPT-teleMG
Yale University
Completed
52 enrolled